Purdue Pharma, U.S. states agree to new opioid settlement
The deal reached Thursday would require members of the Sackler family who own the drugmaker to pay as much as $6 billion in cash.
Stay updated with breaking news from Ed Bisch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The deal reached Thursday would require members of the Sackler family who own the drugmaker to pay as much as $6 billion in cash.
OxyContin maker Purdue Pharma reached a nationwide settlement Thursday over its role in the opioid crisis, with the Sackler family members who own the company boosting their cash contribution to
OxyContin maker Purdue Pharma reached a nationwide settlement Thursday over its role in the opioid crisis, with the Sackler family members who own the company boosting their cash contribution to
Overall, Maryland expects to receive from Purdue and the Sacklers an estimated $121.9 to $132.2 million for opioid treatment and prevention.
OxyContin maker Purdue Pharma reached a settlement Thursday over its role in the opioid crisis that includes virtually all U.S. states and thousands of local governments, with the Sackler family members who own the company boosting their cash contribution to as much as $6 billion.